Chase Heaton, MD

Head and neck and reconstructive surgeon

Dr. Chase M. Heaton is a head and neck and reconstructive surgeon at the UCSF Helen Diller Family Comprehensive Cancer Center. He specializes in treating benign and malignant tumors of the oral cavity, oropharynx, larynx, thyroid, skin and salivary glands. He is fellowship trained in microvascular reconstruction for head and neck cancers. He also has experience in transoral robotic surgery for removal of head and neck tumors. Heaton is committed to working with patients to develop individualized treatment plans to ensure they get the best possible care.

In addition to treating patients, Heaton conducts clinical research on outcomes of head and neck surgery. He also plays an active role in teaching and mentoring UCSF otolaryngology residents and medical students.

Heaton completed undergraduate studies at the University of Notre Dame and earned a medical degree at the Stritch School of Medicine in Chicago. After finishing an otolaryngology-head and neck surgery residency at UCSF, he completed a one-year fellowship in head and neck oncology and microvascular reconstructive surgery at UCSF. He joined the UCSF faculty full-time in 2015.

Heaton is board certified by the American Board of Otolaryngology. He plays an active role in teaching and mentoring UCSF otolaryngology residents and medical students.


Head and Neck Surgery Cancer Clinic
1825 Fourth St., Fourth Floor
San Francisco, CA 94158
Phone: (415) 885–7528
Fax: (415) 885–7711

Hours: Monday to Friday
8 a.m. – 5 p.m.

Academic Title

Assistant Professor

More about Chase Heaton


Loyola University Chicago Stritch School of Medicine 2009


UCSF Medical Center, Otolaryngology-Head and Neck Surgery 2014


UCSF Medical Center, Head and Neck Oncology, Microvascular Reconstructive Surgery

Selected Research and Publications

  1. Xu MJ, Lazar AA, Garsa AA, Arron ST, Ryan WR, El-Sayed IH, George JR, Algazi AP, Heaton CM, Ha PK, Yom SS. Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy. Head Neck. 2018 Mar 10.
  2. Tamplen ML, Tamplen J, Shuman E, Heaton CM, George JR, Wang SJ, Ryan WR. Comparison of Output Volume Thresholds for Drain Removal After Selective Lateral Neck Dissection: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2017 Aug 24.
  3. Naunheim M, Wu X, Ryan WR, Wang SJ, Heaton CM. Volumetric Growth Rate of Recurrent Pleomorphic Adenoma. Ann Otol Rhinol Laryngol. 2017 Jul; 126(7):544-547.
  4. Wang SJ, Asthana S, van Zante A, Heaton CM, Phuchareon J, Stein L, Higuchi S, Kishimoto T, Chiu CY, Olshen AB, McCormick F, Tetsu O. Establishment and characterization of an oral tongue squamous cell carcinoma cell line from a never-smoking patient. Oral Oncol. 2017 Jun; 69:1-10.
  5. Markey JD, Alemi AS, Naunheim ML, Faden DL, Heaton CM, Seth R. Spontaneous Iliopsoas Hematoma following Microvascular Free Tissue Transfer. Case Rep Otolaryngol. 2017; 2017:7631673.
  6. Alemi AS, Seth R, Heaton C, Wang SJ, Knott PD. Comparison of Video and In-person Free Flap Assessment following Head and Neck Free Tissue Transfer. Otolaryngol Head Neck Surg. 2017 Jun; 156(6):1035-1040.
  7. Tamplen ML, Tamplen J, Torrecillas V, Seth R, Ricceri S, Hemmat S, Heaton C, Ryan WR, Knott PD. Does a Standalone Cancer Center Improve Head and Neck Microsurgical Outcomes? J Reconstr Microsurg. 2017 May; 33(4):252-256.
  8. Heaton CM, Ahmed SR, Ryan WR. Transoral robotic surgery (TORS) for excision of a retropharyngeal intramuscular lipoma. Auris Nasus Larynx. 2017 Dec; 44(6):742-744.
  9. Alemi AS, Heaton CM, Ryan WR, El-Sayed I, Wang SJ. Volumetric Growth of Cervical Schwannoma as a Predictor of Surgical Intervention. Otolaryngol Head Neck Surg. 2017 Jan; 156(1):152-155.
  10. Faden DL, Arron ST, Heaton CM, DeRisi J, South AP, Wang SJ. Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers. J Otolaryngol Head Neck Surg. 2016 Sep 17; 45(1):47.
  11. Heaton CM, Yu K, Calkins S, George JR, Ryan WR, Wang SJ. Clinicopathologic characteristics and outcomes of recurrent oropharyngeal squamous cell carcinoma. Am J Otolaryngol. 2016 Nov - Dec; 37(6):513-516.
  12. Heaton CM, Chang JL, Orloff LA. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma. Thyroid. 2016 Mar; 26(3):434-40.
  13. Heaton CM, Al-Shwaiheen F, Liu CS, Yom SS, Ryan WR. Prognostic significance of hyoid bone invasion in advanced base of tongue carcinoma treated by chemoradiation. Clin Otolaryngol. 2015 Jun; 40(3):260-5.
  14. Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma. Laryngoscope. 2014 Jul; 124(7):E267-73.
  15. Heaton CM, Chazen JL, van Zante A, Glastonbury CM, Kezirian EJ, Eisele DW. Pleomorphic adenoma of the major salivary glands: diagnostic utility of FNAB and MRI. Laryngoscope. 2013 Dec; 123(12):3056-60.
  16. Heaton CM, Goldberg AN, Pletcher SD, Glastonbury CM. Sinus anatomy associated with inadvertent cerebrospinal fluid leak during functional endoscopic sinus surgery. Laryngoscope. 2012 Jul; 122(7):1446-9.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.